Enhanc3D Genomics has announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug discovery. The new 3D multi-omics offerings were designed to provide partners with an end-to-end solution to support and enhance decision-making through every stage of the drug discovery and development process. The company claims the platform is based on patented Promoter Capture Hi-C technology, offering high-resolution, genome-wide regulatory maps of any cell type, sub-type, or state, by capturing interactions between promoters and regulatory regions.
Enhanc3D Genomics
The post Drug Development 3D Multi-Omics Solutions appeared first on GEN - Genetic Engineering and Biotechnology News.
Enhanc3D Genomics
The post Drug Development 3D Multi-Omics Solutions appeared first on GEN - Genetic Engineering and Biotechnology News.